Following up on last Thursday's symposium, a bio nikkei affiliate/associate tweeted from the event twice, first tweet was about the opening speech and the second one was about Cynata:
"WM's depression. A lecture by Cynata, Australia, which began clinical trials of iPS cells for the first time in the world, began. Human iPS cells from CDI Inc. are used."
Also, DDNews Pharma, Biotech and Life Science mentioned our second preclinical Asthma study in their latest issue:
"Cymerus MSCs show synergy with dexamethasone
February 2018
MELBOURNE, Australia—Cynata Therapeutics Limited recently announced the receipt of the final report on the effects of Cymerus MSCs in combination with or in comparison to dexamethasone in a preclinical asthma study. Daily administration of the drug resulted in significant anti-inflammatory effects in a mouse model. The corticosteroid reduced airway inflammation by 55 percent and airway inflammation-induced goblet cell metaplasia by roughly 80 percent. It showed only weak anti-remodeling and anti-fibrotic effects, however, and reduced airway hyperresponsiveness by only about 30 percent. Once-weekly dosing of Cymerus MSCs, however, led to marked reductions in airway remodeling, fibrosis and airway hyperresponsiveness (70 to 75 percent). The drug also normalized subepithelial collagen deposition and airway TGF-β1 expression levels equivalent to mice that had not been induced with asthma. Together the treatments demonstrated a synergistic effect that featured the anti-inflammatory effects of dexamethasone alone and the reductions seen with Cymerus MSCs alone."
http://www.ddn-news.com/index.php?newsarticle=12157
- Forums
- ASX - By Stock
- Cyp trading
Following up on last Thursday's symposium, a bio nikkei...
Featured News
Add CYP (ASX) to my watchlist
|
|||||
Last
20.0¢ |
Change
-0.005(2.44%) |
Mkt cap ! $36.11M |
Open | High | Low | Value | Volume |
20.5¢ | 21.5¢ | 20.0¢ | $13.43K | 65.55K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 109917 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 9225 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 109917 | 0.200 |
2 | 68825 | 0.195 |
3 | 122713 | 0.190 |
3 | 65055 | 0.180 |
3 | 7139 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 9225 | 2 |
0.255 | 187726 | 1 |
0.270 | 30000 | 1 |
0.280 | 8209 | 2 |
0.285 | 60000 | 1 |
Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online